(15054787), H. L., (15050051), A. L. F., (15049218), C. Q., (15054784), I. A. V., (15056800), I. P. d., (15056803), R. A., . . . (15008931), J. S. W. (2025). Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.
Chicago Style (17th ed.) Citation(15054787), Hansol Lee, et al. Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy. 2025.
MLA引文(15054787), Hansol Lee, et al. Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy. 2025.